000 | 01182 a2200337 4500 | ||
---|---|---|---|
005 | 20250514000126.0 | ||
264 | 0 | _c20010517 | |
008 | 200105s 0 0 eng d | ||
022 | _a0735-7907 | ||
024 | 7 |
_a10.1081/cnv-100102556 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPastore, R D | |
245 | 0 | 0 |
_aRenal cell carcinoma and interferon at the millennium. _h[electronic resource] |
260 |
_bCancer investigation _c2001 |
||
300 |
_a281-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
700 | 1 | _aPfeffer, L M | |
700 | 1 | _aNanus, D M | |
773 | 0 |
_tCancer investigation _gvol. 19 _gno. 3 _gp. 281-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1081/cnv-100102556 _zAvailable from publisher's website |
999 |
_c11271909 _d11271909 |